Screener/Healthcare/Biotechnology

EYPT

EyePoint Pharmaceuticals, Inc.NASDAQ
$12.73-0.13 (-1.01%)
Small CapUnder $20HealthcareHigh Beta
$3.91
$19.11
$12.07
$12.83
EPS (TTM)$-3.00
P/E Ratio—
Dividend Yield—
Market Cap$1.30B
Volume545K
Prev Close$12.83
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$966K-$59.7M$-0.85—-6183.4%
Q2 '25$5.3M-$59.4M$-0.85—-1114.3%
Q1 '25$24.5M-$45.2M$-0.65—-184.8%
Q4 '24$11.6M-$41.4M$-0.65—-357.3%
Q3 '24$10.5M-$29.4M$-0.5493.0%-279.0%
Q2 '24$9.5M-$30.8M$-0.5885.2%-325.3%
Q1 '24$11.7M-$29.3M$-0.5593.5%-250.6%
Q4 '23$14.0M-$14.1M$-0.32—-100.5%
Get Your Daily Market Recap